Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.
about
Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 DiabetesInhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production.Reply to "Tolerogenic insulin peptide therapy precipitates type 1 diabetes".PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes.Type 1 Diabetes Mellitus in Saudi Arabia: A Soaring Epidemic.Skin-Related Complications Among Adolescents With Type 1 Diabetes Using Insulin Pump Therapy
P2860
Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.
@en
Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.
@nl
type
label
Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.
@en
Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.
@nl
prefLabel
Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.
@en
Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.
@nl
P2860
P356
P1476
Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.
@en
P2093
M A Atkinson
M G von Herrath
P2860
P356
10.1111/CEI.12656
P577
2015-05-19T00:00:00Z